Barbara Collura, Brooke Hayward, Krysten A Modrzejewski, Gilbert L Mottla, Kevin S Richter, Allison B Catherino
{"title":"确定在怀孕前停止不孕症治疗的相关因素:一项全国性调查的结果。","authors":"Barbara Collura, Brooke Hayward, Krysten A Modrzejewski, Gilbert L Mottla, Kevin S Richter, Allison B Catherino","doi":"10.1177/23743735241229380","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this mixed methods, cross-sectional patient survey was to characterize patient experience, to explore the frequency of and reasons for infertility treatment discontinuation and return to infertility treatments. Participants were recruited from United States patient support groups. Participants had received or were receiving ovulation induction (OI) with or without intrauterine insemination (IUI), with or without subsequent <i>in vitro</i> fertilization (IVF), or IVF with no other previous infertility treatment. Live birth was achieved by 62% of participants. Compared with participants treated with OI/IUI only, participants who underwent OI/IUI followed by ≥1 IVF cycle were less likely to consider discontinuing care (64% vs 77%; <i>P</i> = .014) or to discontinue treatment without achieving a pregnancy (40% vs 58%; <i>P</i> = .004). The most commonly cited reasons for treatment discontinuation were financial (62%) and psychological burden/treatment fatigue (58%). Expected versus actual time to pregnancy differed greatly. Continued desire for a child (60%) was the most frequently cited reason for continuing or resuming treatment. Expanded access to treatment, counseling and fostering realistic expectations regarding cumulative time to pregnancy may reduce treatment discontinuation.</p>","PeriodicalId":45073,"journal":{"name":"Journal of Patient Experience","volume":"11 ","pages":"23743735241229380"},"PeriodicalIF":1.6000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10898306/pdf/","citationCount":"0","resultStr":"{\"title\":\"Identifying Factors Associated with Discontinuation of Infertility Treatment Prior to Achieving Pregnancy: Results of a Nationwide Survey.\",\"authors\":\"Barbara Collura, Brooke Hayward, Krysten A Modrzejewski, Gilbert L Mottla, Kevin S Richter, Allison B Catherino\",\"doi\":\"10.1177/23743735241229380\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The purpose of this mixed methods, cross-sectional patient survey was to characterize patient experience, to explore the frequency of and reasons for infertility treatment discontinuation and return to infertility treatments. Participants were recruited from United States patient support groups. Participants had received or were receiving ovulation induction (OI) with or without intrauterine insemination (IUI), with or without subsequent <i>in vitro</i> fertilization (IVF), or IVF with no other previous infertility treatment. Live birth was achieved by 62% of participants. Compared with participants treated with OI/IUI only, participants who underwent OI/IUI followed by ≥1 IVF cycle were less likely to consider discontinuing care (64% vs 77%; <i>P</i> = .014) or to discontinue treatment without achieving a pregnancy (40% vs 58%; <i>P</i> = .004). The most commonly cited reasons for treatment discontinuation were financial (62%) and psychological burden/treatment fatigue (58%). Expected versus actual time to pregnancy differed greatly. Continued desire for a child (60%) was the most frequently cited reason for continuing or resuming treatment. Expanded access to treatment, counseling and fostering realistic expectations regarding cumulative time to pregnancy may reduce treatment discontinuation.</p>\",\"PeriodicalId\":45073,\"journal\":{\"name\":\"Journal of Patient Experience\",\"volume\":\"11 \",\"pages\":\"23743735241229380\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10898306/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Patient Experience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/23743735241229380\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Patient Experience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23743735241229380","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
这项以混合方法进行的横断面患者调查旨在了解患者的经历,探讨不孕症治疗中断和重返不孕症治疗的频率和原因。参与者是从美国患者支持团体中招募的。参与者曾接受或正在接受促排卵(OI)和宫腔内人工授精(IUI),或随后接受或未接受体外受精(IVF),或接受体外受精但之前未接受过其他不孕不育治疗。62%的参与者获得了活产。与只接受过卵巢输卵管介入术/人工授精治疗的参与者相比,接受过卵巢输卵管介入术/人工授精治疗后又接受了≥1次体外受精周期治疗的参与者不太可能考虑终止治疗(64% vs 77%; P = .014),也不太可能在没有怀孕的情况下终止治疗(40% vs 58%; P = .004)。最常见的终止治疗原因是经济负担(62%)和心理负担/治疗疲劳(58%)。预期怀孕时间与实际怀孕时间差别很大。对孩子的持续渴望(60%)是最常被提及的继续或恢复治疗的原因。扩大治疗范围、提供咨询和促进对累积怀孕时间的现实预期可能会减少治疗中断。
Identifying Factors Associated with Discontinuation of Infertility Treatment Prior to Achieving Pregnancy: Results of a Nationwide Survey.
The purpose of this mixed methods, cross-sectional patient survey was to characterize patient experience, to explore the frequency of and reasons for infertility treatment discontinuation and return to infertility treatments. Participants were recruited from United States patient support groups. Participants had received or were receiving ovulation induction (OI) with or without intrauterine insemination (IUI), with or without subsequent in vitro fertilization (IVF), or IVF with no other previous infertility treatment. Live birth was achieved by 62% of participants. Compared with participants treated with OI/IUI only, participants who underwent OI/IUI followed by ≥1 IVF cycle were less likely to consider discontinuing care (64% vs 77%; P = .014) or to discontinue treatment without achieving a pregnancy (40% vs 58%; P = .004). The most commonly cited reasons for treatment discontinuation were financial (62%) and psychological burden/treatment fatigue (58%). Expected versus actual time to pregnancy differed greatly. Continued desire for a child (60%) was the most frequently cited reason for continuing or resuming treatment. Expanded access to treatment, counseling and fostering realistic expectations regarding cumulative time to pregnancy may reduce treatment discontinuation.